Bridge HIV has been a global leader in HIV prevention research for over three decades, serving the Bay Area community by targeting the global HIV pandemic. As your community partner, we are turning some of that focus to the global COVID-19 pandemic by joining the COVID-19 Prevention Network.
The UCSF Clinical Research Site (CRS) is co-located within the largest HIV clinic in San Francisco at Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG). Serving the Bay Area for the last 3 decades, the UCSF CRS has been a pioneer in new finding new HIV treatment and care options. The UCSF CRS has now expanded to include prevention and treatment of COVID-19 and is partnering with Bridge HIV in that work.
The COVID-19 Prevention Network (CoVPN) was formed by the National Institute of Allergy and Infectious Diseases (NIAID) at the US National Institutes of Health to respond to the global COVID-19 pandemic. Using the infectious disease expertise of their existing research networks and global partners, NIAID has directed the networks to address the pressing need for vaccines and monoclonal antibodies (mAbs) against SARS-CoV-2.
Michelle Vega-Spight is a San Francisco born artist currently residing in Portland, Oregon. She specializes in digital illustrations, with a specific interest in portraits. She is inspired by children, families and individuals involved in social justice and community activism. You can see more of her work on Instagram: @morena_artiste or visit her at www.morenaartiste.com